Yumo Xue
Overview
Explore the profile of Yumo Xue including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
15
Citations
153
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
11.
Yao B, Xue Y, Liu Z, Xu M, Tu K, Wang J
Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi
. 2016 Jul;
32(8):1083-7.
PMID: 27412940
Objective To observe the expression level of miR-141 in tumor tissues of human hepatocellular carcinoma (HCC) and determine the effect of miR-141 level on cell proliferation, invasion and migration of...
12.
Yin G, Zhou H, Xue Y, Yao B, Zhao W
Oncol Rep
. 2016 Jul;
36(2):1111-8.
PMID: 27374211
Aberrant expression and function of microRNAs (miRNAs) play a critical role in the development and progression of various human cancers including gastric cancer. However, the clinical significance and underlying mechanisms...
13.
Wang Y, Liu Z, Yao B, Dou C, Xu M, Xue Y, et al.
Tumour Biol
. 2016 Mar;
37(8):11429-41.
PMID: 27002617
Despite advances in the roles of long non-coding RNA (lncRNA) tumor suppressor candidate 7 (TUSC7) in cancer biology, which has been identified as a tumor suppressor by regulating cell proliferation,...
14.
Li Q, Liu Z, Xu M, Xue Y, Yao B, Dou C, et al.
Cancer Lett
. 2016 Mar;
375(1):190-198.
PMID: 26945969
Unlabelled: The p300-CBP-associated factor (PCAF), other than its histone acetyltransferase (HAT) activity, possesses an intrinsic ubiquitination activity that is involved in various transcriptional regulators, including the transcription factor glioma-associated oncogene...
15.
Tu K, Liu Z, Yao B, Xue Y, Xu M, Dou C, et al.
Oncol Rep
. 2016 Feb;
35(4):2382-90.
PMID: 26882953
Previous studies have demonstrated the aberrant expression and oncogenic role of B-cell CLL/lymphoma-3 (BCL-3) in human malignancies. However, the clinical significance of BCL-3 and its biological function in human hepatocellular...